Brief: India's Marksans Pharma June-Qtr Consol Profit Rises
06/08/2018 08:40
Aug 6 (Reuters) - Marksans Pharma Ltd MARK.NS :
* JUNE QUARTER CONSOL PROFIT 248.8 MILLION RUPEES VERSUS
144.2
MILLION RUPEES YEAR AGO
* JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 2.35 BILLION
RUPEES
VERSUS 2.21 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEbGts0p
Further company coverage: MARK.NS
(Reuters.Briefs@thomsonreuters.com)
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg